These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33664229)

  • 1. Small intestinal immune-environmental changes induced by oral tolerance inhibit experimental atopic dermatitis.
    Um HN; Baek JO; Park S; Lee EH; Jang J; Park WJ; Roh JY; Jung Y
    Cell Death Dis; 2021 Mar; 12(3):243. PubMed ID: 33664229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral tolerance inhibits atopic dermatitis-like type 2 inflammation in mice by modulating immune microenvironments.
    Baek JO; Roh JY; Jung Y
    Allergy; 2017 Mar; 72(3):397-406. PubMed ID: 27325577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral tolerance modulates the skin transcriptome in mice with induced atopic dermatitis.
    Baek JO; Lee JR; Roh JY; Jung Y
    Allergy; 2018 Apr; 73(4):962-966. PubMed ID: 29168893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation as a new way for OVA-induced atopic dermatitis of juvenile mice.
    Wang XZ; Huang JL; Zhang J; Li QH; Zhang PP; Wu C; Jia YY; Su H; Sun X
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113183. PubMed ID: 39298815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Ameliorates Ovalbumin-Induced Atopic Dermatitis and Blocks the Progression of Atopic March in Mice.
    Sharma S; Sethi GS; Naura AS
    Inflammation; 2020 Feb; 43(1):358-369. PubMed ID: 31720988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin.
    Katagiri K; Arakawa S; Hatano Y; Fujiwara S
    Arch Dermatol Res; 2008 Nov; 300(10):583-93. PubMed ID: 18528699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A legume product fermented by Saccharomyces cerevisiae modulates cutaneous atopic dermatitis-like inflammation in mice.
    Yeh CY; Jung CJ; Huang CN; Huang YC; Lien HT; Wang WB; Wang LF; Chia JS
    BMC Complement Altern Med; 2014 Jun; 14():194. PubMed ID: 24939647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization.
    Laouini D; Elkhal A; Yalcindag A; Kawamoto S; Oettgen H; Geha RS
    J Allergy Clin Immunol; 2005 Aug; 116(2):390-6. PubMed ID: 16083795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin A deficiency exacerbates extrinsic atopic dermatitis development by potentiating type 2 helper T cell-type inflammation and mast cell activation.
    Yang H; Chen JS; Zou WJ; Tan Q; Xiao YZ; Luo XY; Gao P; Fu Z; Wang H
    Clin Exp Allergy; 2020 Aug; 50(8):942-953. PubMed ID: 32559330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
    Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
    Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (R)-(+)-pulegone suppresses allergic and inflammation responses on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice model.
    Choi YY; Kim MH; Lee H; Jo SY; Yang WM
    J Dermatol Sci; 2018 Sep; 91(3):292-300. PubMed ID: 29933898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin Microbiome in Atopic Dermatitis.
    Edslev SM; Agner T; Andersen PS
    Acta Derm Venereol; 2020 Jun; 100(12):adv00164. PubMed ID: 32419029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19 expression in B cells regulates atopic dermatitis in a mouse model.
    Yanaba K; Kamata M; Asano Y; Tada Y; Sugaya M; Kadono T; Tedder TF; Sato S
    Am J Pathol; 2013 Jun; 182(6):2214-22. PubMed ID: 23583649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous sensitization with superantigen induces allergic skin inflammation.
    Laouini D; Kawamoto S; Yalcindag A; Bryce P; Mizoguchi E; Oettgen H; Geha RS
    J Allergy Clin Immunol; 2003 Nov; 112(5):981-7. PubMed ID: 14610492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outstanding animal studies in allergy II. From atopic barrier and microbiome to allergen-specific immunotherapy.
    Jensen-Jarolim E; Pali-Schöll I; Roth-Walter F
    Curr Opin Allergy Clin Immunol; 2017 Jun; 17(3):180-187. PubMed ID: 28375932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of kestose on gut mucosal immunity in an atopic dermatitis mouse model.
    Kim HJ; Lee SH; Go HN; Ahn JR; Kim HJ; Hong SJ
    J Dermatol Sci; 2018 Jan; 89(1):27-32. PubMed ID: 29111180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prostaglandin D₂ receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge.
    He R; Oyoshi MK; Wang JY; Hodge MR; Jin H; Geha RS
    J Allergy Clin Immunol; 2010 Oct; 126(4):784-90. PubMed ID: 20713302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flightless I Alters the Inflammatory Response and Autoantibody Profile in an OVA-Induced Atopic Dermatitis Skin-Like Disease.
    Kopecki Z; Stevens NE; Chong HT; Yang GN; Cowin AJ
    Front Immunol; 2018; 9():1833. PubMed ID: 30147695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis.
    Gaffal E; Glodde N; Jakobs M; Bald T; Tüting T
    Exp Dermatol; 2014 Jun; 23(6):401-6. PubMed ID: 24750433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local but not systemic administration of IFN-gamma during the sensitization phase of protein antigen immunization suppress Th2 development in a murine model of atopic dermatitis.
    Wang LF; Wu JT; Sun CC
    Cytokine; 2002 Aug; 19(3):147-52. PubMed ID: 12242081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.